-

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against iQIYI, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against iQIYI, Inc. (“iQIYI” or the “Company”) (NASDAQ: IQ). The investigation concerns whether iQIYI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

On August 13, 2020, iQIYI issued a press release announcing the Company’s financial results for the second quarter of 2020. Among other results, iQIYI disclosed that the Securities and Exchange Commission's Division of Enforcement “is seeking the production of certain financial and operating records dating from January 1, 2018, as well as documents related to certain acquisitions and investments that were identified in a report issued by short-seller firm Wolfpack Research in April 2020.” On this news, iQIYI's American depositary receipt (“ADR”) price fell $2.42 per ADR, or 11.16%, to close at $19.26 per ADR on August 14, 2020.

If you purchased or otherwise acquired iQIYI securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at investigations@kmllp.com, or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:IQ

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
investigations@kmllp.com

Social Media Profiles
More News From Kirby McInerney LLP

INVESTOR ALERT: Securities Class Action Filed Against Richtech Robotics Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ:RR) securities during the period of January 27, 2026 through January 29, 2026, inclusive (“the Class Period”). If you suffered a loss on your Richtech investments, you have until April 3, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications sub...

INVESTOR ALERT: Securities Class Action Filed Against Ramaco Resources, Inc. – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ:METC) securities during the period of July 31, 2025 through October 23, 2025, inclusive (“the Class Period”). If you suffered a loss on your Ramaco investments, you have until March 31, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitt...

REMINDER: Ardent Health, Inc. Investors With Significant Losses Must Act By March 9, 2026

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) investors of the March 9, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead p...
Back to Newsroom